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Executive Summary 2014
The annual publication of the Massachusetts STD, HIV/AIDS, and Viral Hepatitis
Surveillance Report provides an occasion to reflect upon trends in these diseases
within the Commonwealth of Massachusetts.
In 2014, the following trends in the three most commonly reported bacterial sexually
transmitted infections (STIs) in Massachusetts were observed:
• After reaching a ten-year high of 10.4 per 100,000 in 2013, the incidence 
rate of infectious syphilis (primary, secondary, and early latent syphilis) 
decreased by 14% to 8.9 per 100,000 in 2014. Despite this recent 
decline, syphilis remains at epidemic levels among men who have sex 
with men. Please interpret this decline and all other 2014 STI data with 
caution as it is the first year of a new surveillance system with different 
data collection methods. 
• The total number of gonorrhea cases increased in 2014 by 16%, with a 
27% increase in the number of gonorrhea cases among men. Among 
those individuals with known race and ethnicity, gonorrhea continues to 
disproportionately affect non-white populations living in major urban centers.
• Chlamydia cases have plateaued at approximately 24,000 cases reported 
in each of the past three years (2012 to 2014). Case ascertainment is 
reflective of access to screening with more sensitive laboratory tests. 
Screening for C. trachomatis among vulnerable populations, especially 
sexually active young women, remains important for early diagnosis, 
treatment and prevention of pelvic inflammatory disease.1
Regarding HIV/AIDS, notable trends through 20132 included the following:
• The number of new HIV diagnoses in Massachusetts decreased 29% from
2001 to 2013, and the number of deaths in HIV-positive persons decreased 53%.
• Due to improved survival and lower rates of death, the number of persons 
known to be living with HIV/AIDS in Massachusetts increased 50% between
2001 and 2013 to over 19,000 HIV-positive state residents. 
• Black, non-Hispanic and Hispanic/Latino residents have significantly higher
rates of HIV infection compared to white residents. This is most notable in 
women as 80% of women newly diagnosed between 2011 and 2013 were 
black, non-Hispanic or Hispanic/Latina.
• Male-to-male sex remains the single most frequently identified exposure 
mode among newly diagnosed cases of HIV infection, and represents 60% 
of newly diagnosed cases among men.
With regard to viral hepatitis, we observed the following trends through 2014:
• Hepatitis C remains one of the highest volume reportable diseases, with an 
average of over 5,600 confirmed cases reported in each of the past ten 
years (2005 to 2014). There continues to be an increase of hepatitis C cases 
reported among adolescents and young adults, reflecting ongoing transmission 
among young people injecting drugs.
• Confirmed new cases of chronic hepatitis B continued to decline, due in large
part to near universal immunization of children. Given that immigrants from 
endemic countries are at highest risk for chronic hepatitis B infection, any 
shifts in testing access for this population could also influence the number 
of reported cases.
1 Oakeshott, P., et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory
disease: the POPI (prevention of pelvic infection) trial. BMJ, 2010. 340: c1642.
2 Due to reporting delays related to site-specific reporting issues, all HIV/AIDS data reflect HIV diagnosed through 2013.
Highlighted on pages 16–23 are trends within special populations disproportionally
affected by STIs, HIV/AIDS, and/or viral hepatitis. Massachusetts data are reflective
of a number of national trends among women, minorities (both sexual and racial/
ethnic minorities), and youth. 
The focus of this annual surveillance report is on trends in reportable diseases. While
the report is not a full exploration of social and behavioral determinants of health, a
range of health disparities are noted and described. However, it should be recognized
that STIs, including HIV/AIDS and viral hepatitis, occur at the nexus of individual human
behavior, community risk, clinical diagnosis and treatment, and public health prevention
and disease control. The intended audience for this annual surveillance report includes
the clinicians and the laboratory professionals who report these cases, as well as the
community organizations, local public health departments, advocates, policymakers,
and researchers who are interested in the health of Massachusetts residents who may
be vulnerable to sexually transmitted infections, viral hepatitis infection, or HIV infection.
We welcome feedback, and invite you, the reader, to begin by thinking in terms of 
disease statistics, but end by acting in terms of health promotion.
Daniel Church, MPH, Viral Hepatitis Prevention Coordinator, Division of Epidemiology 
and Immunization
Katherine Hsu, MD, MPH, Medical Director, Division of STD Prevention and
HIV/AIDS Surveillance
Betsey John, MPH, Director, HIV/AIDS and STD Surveillance
Kathleen Roosevelt, MPH, Director, Division of STD Prevention
H. Dawn Fukuda, ScM, Director, Office of HIV/AIDS
Patricia Kludt, MPH, Director, Epidemiology Program 
Larry Madoff, MD, Director, Division of Epidemiology and Immunization
Alfred DeMaria, Jr., MD, Medical Director and State Epidemiologist, Bureau of 
Infectious Disease 
Kevin Cranston, MDiv, Director, Bureau of Infectious Disease 
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In 2014, there were 24,143 reported chlamydia
cases in Massachusetts, making chlamydia 
the most frequently reported infection in the
Commonwealth. The total number of reported
chlamydia cases in Massachusetts increased
from 14,477 in 2005 to 24,143 in 2014. 
Additional information about chlamydia
infection and other STIs is available online at
www.mass.gov/dph/cdc/std.
Chlamydia infection is widely distributed in 
Massachusetts. There were no major shifts 
in the geographic distribution of cases 
within the state in the past year. The overall
Massachusetts chlamydia incidence rate of
357.9 per 100,000 population is lower than 
the national rate of 456.1 per 100,000.3
Massachusetts ranked fifth lowest in 
chlamydia incidence among the 50 states. 
The five cities in Massachusetts with the 
highest chlamydia incidence rates were
Lawrence, Chelsea, Springfield, Provincetown,
and Boston. Throughout the state, the majority
of cities and towns fell into the range of 50 to
200 cases per 100,000.
The chlamydia incidence rate among women
remained two to three times higher than the
rate among men from 2005 to 2014. The
greater chlamydia incidence rate among
women reflects a higher level of screening.
There was an 11% increase in the chlamydia
incidence rate among men in 2014 compared
to 2013 and a 2% decrease in the incidence
rate among women. 
3 Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2014. Atlanta: U.S. Department
of Health and Human Services; 2015.
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The chlamydia incidence rate remained highest
among adolescents and young adults from 2005
to 2014. In 2014, the chlamydia incidence rate
in Massachusetts among adolescents (ages
15–19) was 1,219.7 per 100,000, compared to
1,804.0 nationally. The rate among young adults
(ages 20–24) in Massachusetts was 1,969.0
cases per 100,000, compared to 2,484.6 nationally.
For the first time in ten years, there was a 
decrease in the incidence rate among both the
youngest age groups in 2013 compared to
2012. In 2014 compared to 2013, the chlamydia
incidence rate continued to decrease among
young adults (ages 20–24) by 4% but increased
by 12% among adolescents (ages 15–19).
Please note that cases reported without gender, age
category and race/ethnicity have been redistributed
by the proportional distribution of cases with known
gender, age, and race/ethnicity for STI incidence
rate calculations. The proportion of chlamydia
cases reported without gender and age category
remained low (<1%) after a mid-year transition to 
a new surveillance system in 2014. However,
the proportion of chlamydia cases reported with
unknown race/ethnicty increased to 49% in 2014,
from 35% in 2013. Thus, caution should be used 
in interpretation of all 2014 chlamydia data, 
particularly the race/ethnicity data. Historically,
members of communities of color have been 
disproportionately affected by STIs. In 2014, 
compared to the white population, the incidence rate
of reported chlamydia infection in Massachusetts
was seven times higher in the black and five times
higher in the Hispanic/Latino population. Disparities
in the chlamydia incidence rate in Massachusetts
have decreased in recent years. In 2005, the
chlamydia incidence rate was 12 times higher in
the black and 11 times higher in the Hispanic/Latino
population, compared to the white population. 
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Since 1997, the Division of STD Prevention has partnered with other agencies to reduce infertility
and other health consequences of chlamydia infection through screening and treatment of women
who are at higher risk for infection.
In 2014, 10,090 specimens were tested for chlamydia infection and 6.6% were positive. Among
these specimens, 7,688 were also tested for gonorrhea, 1.9% were positive. Test results from 
selected sites have yielded the following: 
CHLAMYDIA SCREENING PROJECTS, PERCENT POSITIVE 
FOR CHLAMYDIA INFECTION AMONG WOMEN, MASSACHUSETTS 2014
SITE TYPE NUMBER TESTED % POSITIVE
School-Based Health Centers 942 8.5%
Correctional Facilities 313 8.3%
Family Planning Clinics 3,056 6.7%
Hospital Based Clinic 360 11.4%
Expanded STD Screening Sites* 3,650 7.6%
Data Source: MDPH Bureau of Infectious Disease
*Includes women under age 26 years, tested at Prevention, Integrated Counseling, Screening, and Referral sites under former IPP 
funding now known as Safety Net Services.
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The number of gonorrhea cases in 
Massachusetts in 2014 was 3,657, a 16% 
increase from the previous year. There have
been year-to-year fluctuations in gonorrhea
case number, but since 2011, the number has
increased each year. Additional information
about gonorrhea and other STIs is available
online at www.mass.gov/dph/cdc/std.
The Massachusetts gonorrhea incidence rate of
54.2 per 100,000 is about half the national rate
of 110.7 per 100,000.4 Massachusetts ranked
eleventh lowest in gonorrhea incidence rate
among the 50 states. Incidence is clustered
around urban areas, with the five highest rates
in the cities of Provincetown, Boston, Brockton,
Chelsea, and Taunton.
From 2005 to 2009, the gonorrhea incidence
rate reported among men was about the same
as the rate reported among women. From 2009
to 2014, the gonorrhea incidence rate reported
among men more than doubled (from 31.2 per
100,000 to 76.7 per 100,000) while the rate
among women increased by only 19% (from
27.7 per 100,000 to 33.0 per 100,000).
4 Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2014. Atlanta: U.S. 
Department of Health and Human Services; 2015.
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From 2005 to 2014, the gonorrhea incidence
rate per 100,000 was highest among young
adults ages 20 to 24 years (231.4 per 100,000
in 2014). In 2014, the gonorrhea incidence rate
among young adults (ages 20 to 24 years old)
was four times the state-wide incidence rate in
all ages; among 25 to 29 year olds (175.2 per
100,000) it was three times that incidence rate
(54.2 per 100,000).
Please note that cases reported without gender,
age category, and race/ethnicity have been 
redistributed by the proportional distribution of
cases with known gender, age, and race/ethnicity
for STI incidence rate calculations. The proportion
of gonorrhea cases reported without gender and
age category remained low (<1%) after a mid-year
transition to a new surveillance system in 2014.
However, the proportion of gonorrhea cases
reported with unknown race/ethnicty increased 
to 39% in 2014, from 24% in 2013. Thus, caution
should be used in interpretation of all 2014 
gonorrhea data, particularly the race/ethnicity data.
In 2014, the reported gonorrhea incidence rate in
Massachusetts was ten times higher in the black
population (294.0 cases per 100,000) and four
times higher in the Hispanic/Latino population
(99.5 cases per 100,000) compared to the white
population (28.4 cases per 100,000). Disparities
in the gonorrhea incidence rate in Massachusetts
have decreased in recent years. In 2005, the 
gonorrhea incidence rate was 16 times higher in
the black and seven times higher in the Hispanic/
Latino population, compared to the white population.
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The number of infectious syphilis cases (primary,
secondary, and early latent) reported in 
Massachusetts increased from 231 in 2005 to
701 in 2013 and then declined to 600 in 2014.
Please interpret this decline with caution as it
is the first year of a new surveillance system 
with different data collection methods. Additional
information about infectious syphilis is available
online at www.mass.gov/dph/cdc/std.
Although infectious syphilis cases were reported
in almost all counties in 2014, 38% of the cases
were reported in Suffolk County, 19% were 
reported in Middlesex County, and 8% were 
reported in Hampden County. After reaching a
ten-year high of 10.4 per 100,000 in 2013, the
infectious syphilis rate decreased by 14% to 
8.9 per 100,000 in 2014. The highest infectious
syphilis rate was in Suffolk County (31.6 per
100,000; followed by Barnstable and Hampden
(both at 9.7 per 100,000). Middlesex, Bristol,
Essex and Norfolk had syphilis rates between
six and eight per 100,000; Worcester, Franklin,
Plymouth, Hampshire, and Berkshire Counties
had syphilis rates less than or equal to five per
100,000; Dukes and Nantucket Counties had 
no reported cases.
The infectious syphilis incidence rate per
100,000 among men increased from 6.8 per
100,000 in 2005 to 19.9 per 100,000 in 2013,
and then decreased to 16.7 per 100,000 in
2014. The infectious syphilis incidence rate
among women increased from 0.6 per 100,000
in 2005 to 1.5 per 100,000 in 2014.
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In 2014, the infectious syphilis rate per 100,000
was highest among individuals 25 to 29 years
(24.9 per 100,000), followed by individuals 20 to
24 years and 30 to 39 years (18.7 and 18.8 per
100,000, respectively). In 2014, the infectious
syphilis incidence rate among individuals 20 to
24 years, 25 to 29 years, and 30 to 39 years
was more than double the overall incidence rate
of 8.9 per 100,000.
Please note that cases reported without gender,
age category, and race/ethnicity have been 
redistributed by the proportional distribution of
cases with known gender, age, and race/ethnicity
for STI incidence rate calculations. The proportion
of syphilis cases reported without gender and age
category remained low (<1%) after a mid-year
transition to a new surveillance system in 2014.
However, the proportion of syphilis cases reported
with unknown race/ethnicty increased slightly to
7% in 2014, from 4% in 2013. Thus, caution
should be used in interpretation of all 2014 syphilis
data, particularly the race/ethnicity data. In 2014,
the infectious syphilis incidence rate was more
than three times higher in the black population
(21.7 cases per 100,000) and four times higher in
the Hispanic/Latino population (24.8 cases per
100,000) compared to the white population (6.2
cases per 100,000). 
CONGENITAL SYPHILIS
Reported cases of probable congenital syphilis are occurring again in Massachusetts after eight years
of no cases being reported. In 2010 there was a single case, in 2011 there were no cases, in 2012
there was one case, 2013 had four cases, and 2014 had five cases (7.0 cases per 100,000 live births).
This subtle increase parallels increases in infectious syphilis being reported in reproductive age
women aged 15-49 years in Massachusetts. This also mirrors national trends, where after a period
of decline from 2008 to 2012, congenital syphilis rates increased by 38% between 2012 and 2014:
from 8.4 to 11.6 cases per 100,000 live births. The few cases of congenital syphilis occurring in
Massachusetts were born to women with little or no prenatal care or women who were not known to
be at high risk for syphilis infection who therefore did not receive repeat syphilis screening in the third
trimester or at delivery. 
5 Definition of probable congenital syphilis: http://www.cdc.gov/std/stats/congenitalsyphilisdef-rev-jan-2015.pdf
6 Bowen V et al. Increase in Incidence of Congenital Syphilis – United States, 2012–2014. MMWR Morb Mortal Wkly Rep
2015;64:1241-5.
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Of the 351 cities and towns in Massachusetts,
204 (58%) had at least one reported HIV
infection diagnosis from 2011 to 2013. The 
majority of HIV infection diagnoses were 
reported in people living in large urban areas. 
Of those cities and towns where HIV infections
were diagnosed within the three-year period
2011 to 2013, the majority (85%) had rates
under ten per 100,000 population. Provincetown
had the highest rate of HIV infection diagnosis
at 294.6 per 100,000 population, followed by
Chelsea at 35.1 per 100,000 and Boston at 30.6
per 100,000. HIV infection case and incidence
data by city and town are available online at
www.mass.gov/dph/cdc/aids.
Additional information is available through the 
MDPH HIV/AIDS Epidemiologic Profile at the 
same weblink.
In 2013, there were 698 HIV infections diagnosed and 188 deaths among people reported with HIV in Massachusetts. In
the past five years, the number of HIV infection diagnoses has stabilized while deaths among people reported with HIV
have declined. Because new HIV infection diagnoses continue to exceed the number of deaths annually, the number of
people known to be living with HIV/AIDS in Massachusetts has increased by 29% from 14,986 on December 31, 2004 to
19,279 on December 31, 2013. 
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From 2011 to 2013, of the 2,104 HIV infections
diagnosed in Massachusetts, 1,553 (74%) were
in men and 551 (26%) were in women. Most of
the newly diagnosed HIV infections in men were
in white men, whereas the majority of newly 
diagnosed HIV infections in women were in
black women.
From 2011 to 2013, the primary risk reported 
for HIV infection diagnoses in Massachusetts
was male-to-male sex at 44%, followed by 
presumed heterosexual sex (13%), 
heterosexual sex (10%), and injection drug 
use (7%). Twenty-three percent of diagnoses
were reported without adequate risk 
information.
Since the mid-1990s, Massachusetts has 
experienced a dramatic reduction in mother-
to-child transmission of HIV infection. From
2004 to 2013, the number of HIV-infected 
newborns identified ranged from zero to four
per year. The decline is attributable to the 
high rates of antiretroviral treatment in HIV+
women, and improvements in HIV screening
during pregnancy. However, every case of
mother-to-child transmission remains a 
sentinel event mandating investigation to
identify if new systems can be put in place
to assure maximum efforts to prevent vertical
transmission.
Page 11
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The number of confirmed cases of chronic 
infection with hepatitis B virus (HBV) reported
in Massachusetts has been declining since
2005. In 2014, 259 chronic HBV infections
were confirmed. The decline is due in large
part to almost universal immunization of 
children against HBV. Any shifts in testing 
access for immigrants from endemic 
countries may also impact these numbers.
The incidence rate of confirmed chronic HBV
per 100,000 among men decreased from 21.8
per 100,000 in 2005 to 4.1 per 100,000 in
2014. The chronic HBV incidence rate among
women decreased from 15.3 per 100,000 in
2005 to 3.6 per 100,000 in 2014.
Thirty-one confirmed cases of acute HBV 
were identified in 2014. Confirmation of acute
infection is challenged by the requirement of
clinical information not always provided to
MDPH and the high proportion of asymptomatic
acute HBV cases. Thus, the number of reported
confirmed acute cases of HBV infection is 
an underestimate of the true number of acute
infections in the state.
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Due to enhanced surveillance focused on 
pregnant women, a large number of the 
hepatitis B cases identified and reported in 
2014 were in women between the ages of 
15 and 49 years (35%, N=90). The Department
makes every effort to identify infection among
household and sexual contacts of these women.
It is recommended that pregnant women be screened for HBV during each pregnancy to allow
case management to begin early and prevent mother-to-child transmission. Babies of infected
mothers can be protected by administration of hepatitis B immune globulin and hepatitis B vaccine
at birth (post-exposure prophylaxis or PEP) and timely completion of the three-dose hepatitis B
vaccine series. Since 2007, the Perinatal Hepatitis B Program has partnered with local public
health agencies to increase identification of household and sexual contacts of hepatitis B surface
antigen (HBsAg)-positive pregnant women in an effort to reduce transmission. Uninfected contacts
can be vaccinated to prevent infection.
PERINATAL HEPATITIS B PROGRAM
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The annual number of newly diagnosed hepatitis
C cases reported in Massachusetts since 2004
remains high with 7,000 to 10,000 probable and
confirmed cases reported each year. There were
5,802 confirmed hepatitis C cases reported to
MDPH in 2014. Hepatitis C virus remains one of
the highest volume infectious diseases reported
in Massachusetts. 
A change in the acute hepatitis C case definition
was adopted by the Centers for Disease Control
and Prevention (CDC) in 2012. Formerly, rule-
out of acute hepatitis A and B infection was 
required to confirm a case. Due to the difficulty
in obtaining these laboratory test results, this 
led to a small number of confirmed acute cases.
The increase seen in 2013 and 2014 cases
reflects the case definition change that lifted 
this requirement. Acute cases of hepatitis C are
reported in CDC’s annual summary of notifiable
diseases (available at http://www.cdc.gov/hepati-
tis/statistics/2013surveillance/index.htm), while
chronic hepatitis C is not.
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The age distribution of hepatitis C cases
reported in Massachusetts has changed 
between 2002 and 2014. In 2002, reported
cases were distributed in a curve with one 
age peak at 45 years. In 2014, the reported
cases were distributed in a bi-modal curve 
with one peak at 25 years of age and a 
second peak at around 55 years.
More hepatitis C cases reported in 2014 are
identified in men than in women in almost all age
groups, except for the 15 to 19 year age group,
where the number of women is the same as
men (N=50). The majority of new hepatitis C
infections in persons less than 30 years of age
are attributable to blood exposure in the context
of injection drug use.
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Nationally, prevalence estimates suggest
that nearly half of all new STIs occur among
adolescents and young adults aged 15–24
years.8 In Massachusetts, 64% of chlamydia
cases and 43% of gonorrhea cases were 
reported in this age group in 2014. 
From 2011 to 2013, 14% of HIV infection diagnoses were reported among adolescents and young adults
aged 15–24 years. Their racial/ethnic distribution was: white (non-Hispanic) (36%), black (non-Hispanic)
(31%), Hispanic/Latino (27%), and other (5%).
Compared to older adults, sexually active adolescents and young adults are at higher risk for 
acquiring STIs because of a combination of behavioral, biological, and social factors. The higher
prevalence of STIs among adolescents may also reflect multiple barriers to accessing quality 
STI prevention services, including lack of insurance or other ability to pay for services, lack of
transportation, discomfort with facilities and services designed for adults, conflict with clinic hours
and school schedules, concerns about confidentiality, and embarrassment.7
7 Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2014. Atlanta: U.S. 
Department of Health and Human Services; 2015.
8 Satterwhite CL et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates,
2008. Sexually Transmitted Disease. 2013;40(3):187-93.
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From 2011 to 2013, the primary reported risk
for HIV infection in adolescents and young
adults was male-to-male sex (61%), followed
by presumed heterosexual sex (10%), 
heterosexual sex (6%), MSM/IDU (4%), 
and injecting drug use (2%). Fifteen percent 
of adolescents and young adults were 
reported with no risk information.
The Youth Risk Behavior Survey (YRBS) is performed biennially among a sample of
ninth to twelfth grade students. A review of data provided from the Massachusetts
YRBS from 2005 to 2013 indicates that three indicators of high risk youth sexual 
behavior (ever having had sex, first sex before age 13 years, and four or more lifetime
sexual partners) reached their lowest levels in 2013 (respectively 38%, 3%, and 9%).
Lifetime injection drug use reached a low in 2013 of 1%. In contrast, two protective
correlates of sexual behavior, use of condoms at last sex and being taught about
HIV/AIDS in school, have shown declines from previous gains (respectively, 58% in
2013 down from 65% in 2005, and 85% in 2013 down from 93% in 2005).
REPORTED SEXUAL BEHAVIORS AMONG MASSACHUSETTS HIGH
SCHOOL STUDENTS, 2005–20131
AFFIRMATIVE RESPONSES (percent)
2005 2007 2009 2011 2013
Lifetime sexual intercourse 45 44 46 42 38
Sexual intercourse before age 13 5 6 5 4 3
Four or more lifetime sexual partners 13 12 13 11 9
Lifetime injection drug use 2 3 2 2 1
Condom use at last sexual intercourse 65 61 58 58 58
Ever taught in school about AIDS or HIV 93 89 87 84 85
1 Unweighted sample size by year: 2013 (N=2,718), 2011 (N=2,729), 2009 (N=2,707), 2007 (N=3,131), 2005 (N=3,522)
Data source: Massachusetts Department of Elementary and Secondary Education, Massachusetts Youth Risk Behavior Survey
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Unlike gonorrhea, chlamydia infection in
Massachusetts is more commonly reported
in women. From 2005 to 2012, the number 
of chlamydia cases in women increased by
56%, then decreased by 5% in 2014. The 
increase in the number of cases in the past
ten years is in part due to increased adoption
of routine screening by Massachusetts health-
care providers, as recommended by the 
Centers for Disease Control and Prevention.
In 2014, women were over-represented among
chlamydia cases by a ratio of two to one. The
greater number of chlamydia cases in women 
is attributable in part to increased screening in
women as compared to men.
From 2013 to 2014, the number of gonorrhea
cases among women decreased by 3% (from
1,180 to 1,144) while the number of cases
among men increased by 27% (from 1,965 to
2,500).
In women, untreated STIs can lead to serious health consequences including pelvic inflammatory
disease, infertility, ectopic pregnancy, and cervical cancer. Women are disproportionately impacted
by STI complications because STIs are more likely to remain undetected, delaying treatment.
While women are highly susceptible to infection anatomically, they are less likely to have symptoms
and if they do exhibit symptoms, more likely to attribute them to something else. Additionally,
women may be less able to negotiate safer sex practices than men, further increasing their risk
for STIs.9,10
9 Centers for Disease Control and Prevention. CDC Fact Sheet, 10 Ways STDs Impact Women Differently from Men. 
April 2011. 
10 Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2014. Atlanta: U.S. 
Department of Health and Human Services; 2015.
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From 2011 to 2013, the reported risk for the 
551 HIV infections diagnosed in women in 
Massachusetts were attributed to presumed 
heterosexual sex (50%), heterosexual sex
(23%), injection drug use (11%), and other 
exposure modes (1%). Fifteen percent of
women were reported with no identified risk 
for HIV exposure.
From 2011 to 2013, 49% of women diagnosed
with HIV infection were born outside of the U.S.
For men diagnosed from 2011 to 2013, only 
28% were born outside of the U.S.
Eighty-five percent of women diagnosed with
HIV infection who were born outside of the 
U.S., were born in regions of the world where
heterosexual sex is the predominant mode 
of transmission of HIV infection.
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Although communities of color represent only
26% of the total Massachusetts population,
these communities bear a disproportionate
burden of STIs and HIV. In 2014, 48% of 
infectious syphilis cases, 61% of gonorrhea
cases, and 60% of chlamydia cases where
race and ethnicity are known occurred in
individuals from communities of color.
From 2011 to 2013, the racial/ethnic distribution
of HIV infection in Massachusetts was: white
(non-Hispanic) (37%), black (non-Hispanic)
(31%), Hispanic/Latino (27%), and other/
unknown (4%).
National surveillance data show higher rates of reported STIs among some racial or ethnic minority
groups when compared with rates among white residents. Race and ethnicity in the United States
are risk markers that correlate with other more fundamental determinants of health status, such
as poverty, unemployment, low educational attainment, access to quality health care, and living
in communities with high prevalence of STIs. “Acknowledging the inequity in STD rates by race or
ethnicity is one of the first steps in empowering affected communities to organize and focus on
this problem.” 11
11 Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2014. Atlanta: U.S. Department
of Health and Human Services; 2015.
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In Massachusetts, in 2015, the prevalence rate
of people living with HIV/AIDS was highest
among the black (non-Hispanic) and
Hispanic/Latino populations. As compared to 
the white (non-Hispanic) population, the rate 
of people living with HIV/AIDS was ten times
higher among the black (non-Hispanic) 
population and seven times higher among the
Hispanic/Latino population.
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The proportion of infectious syphilis cases
among MSM remained above 65% from 2005
to 2014. During this time period the number 
of reported cases among MSM more than 
doubled, from 167 to 397.
The racial/ethnic distribution of infectious
syphilis cases reported in 2014 among MSM
was: white (non-Hispanic) (53%), black 
(non-Hispanic) (15%), Hispanic/Latino (18%),
and other (8%). An additional 6% of cases 
were reported with unknown race/ethnicity. 
The median age of infectious syphilis cases 
reported among MSM was 34 years.
Notifiable disease surveillance data on syphilis and data from the National Gonococcal Isolate
Surveillance Project suggest that some STIs are increasing in MSM, including men who have 
sex with both men and women. These data also indicate that MSM are more likely to develop 
antimicrobial resistance compared to heterosexual men and women. Because STIs and the 
behaviors associated with acquiring them increase the likelihood of acquiring and transmitting HIV
infection, the rise in STIs among MSM may be associated with the increase in HIV diagnosis
among MSM nationally.12 Additional information and resources regarding MSM and STIs is available
online at http://www.mass.gov/eohhs/gov/departments/dph/prog-a-j/bcdc/factsheets.html
In Massachusetts, MSM represent the most frequently reported risk group for infectious syphilis.
Of the 600 infectious syphilis cases in 2014, 397 (66%) were reported in men known to be MSM.
Forty percent (N=158) of the MSM with infectious syphilis disclosed that they were co-infected
with HIV. Forty-two percent of the infectious syphilis cases in MSM were reported in Suffolk County
and 18% were reported in Middlesex County. 
12 Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2014. Atlanta: U.S. Department
of Health and Human Services; 2015.
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In 2014, 40% (N=158) of the MSM with 
infectious syphilis disclosed that they were 
co-infected with HIV. 
Among men, the proportion of reported HIV 
infection cases with male-to-male sex as the 
reported mode of exposure increased from 
45% in 2004 to 60% in 2013.
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STRENGTHS AND LIMITATIONS OF DATA
HIV/AIDS Case Data
• Collected by MDPH 
Bureau of Infectious 
Disease, HIV/AIDS 
Surveillance Program.
• Reportable statewide.
• All laboratories and 
healthcare providers are 
required by law to report. 
• HIV infection and 
AIDS cases are reported 
by name.
• Individuals diagnosed 
out of state have been 
excluded in analysis.
• Risk information is 
available. 
• Completeness of race/
ethnicity data is high.
• Comparable with other 
states.
• Under-reporting 
(10%–15%) hampers 
interpretation of HIV/AIDS
case data.
• Not all HIV/AIDS cases 
are reported at time of 
diagnosis (reporting lag).
• HIV/AIDS data may be 
incomplete because 
some HIV-infected people
may not have been 
tested or have entered 
care.
STI Case Data
• Collected by MDPH 
Bureau of Infectious 
Disease, Division of 
STD Prevention. 
• Reportable statewide.
• All laboratories and health-
care providers are required 
by law to report STIs 
(including syphilis, gonorrhea, 
chlamydia infection, 
lymphoma granuloma 
venereum, chancroid, 
granuloma inguinale, 
neonatal herpes infection, 
pelvic inflammatory disease 
(PID) and opthalmia 
neonatorum).
• Comparable with other 
states.
• Enhanced reporting of 
positive laboratory results.
• Under-reporting of up to 
10% of STI cases.
• Race/ethnicity data 
are missing in 49% of 
chlamydia, 39% of 
gonorrhea and 7% of 
infectious syphilis cases 
in 2014.
• Bias is introduced for 
some STIs, such as 
chlamydia infection, 
where screening of 
asymptomatic persons 
occurs more frequently 
in women than in men.
Viral Hepatitis Case Data
• Collected by MDPH 
Bureau of Infectious 
Disease, Office of 
Integrated Surveillance 
and Informatics Services.
• Reportable statewide.
• All laboratories and 
healthcare providers are 
required to report cases, 
or laboratory indicators, 
of hepatitis B and C 
infection.
• Enhanced surveillance 
of hepatitis B cases in 
child-bearing aged 
women and children
and hepatitis C infection 
among cases ages 
15–29 years.
• Race data are missing in 
25% of confirmed chronic 
hepatitis B and 39% of 
confirmed hepatitis C 
cases in 2014; ethnicity 
data are missing in 41% 
of confirmed chronic 
hepatitis B and 60% of 
confirmed hepatitis C 
cases in 2014.
• Risk history data are 
inconsistently reported for
acute hepatitis B cases 
and both acute and 
chronic hepatitis C cases. 
Risk history data are not 
collected on chronic 
HBV cases.
Description
Strengths
Limitations
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INTERPRETING STI, HIV/AIDS, AND VIRAL HEPATITIS DATA
Hepatitis B data reported are current as of June 8, 2015, hepatitis C data are as of June 29, 2015, HIV/AIDS data
are as of January 1, 2015, and all STI data are as of September 29, 2015. All data are subject to change. 
I. HIV/AIDS Exposure Mode Definitions
The HIV/AIDS exposure mode indicates the most probable risk behavior associated with HIV infection. 
Assignment of exposure mode is done in accordance with Centers for Disease Control and Prevention
guidelines when multiple exposure modes are reported. Following is a description of the exposure mode 
categories:
• MSM (Male to Male Sex): Includes males who report sexual contact with other males, and males who 
report sexual contact with both males and females. Please note the acronym MSM is also used to refer to 
“men who have sex with men”.
• IDU (Injection Drug Use): Cases in persons who report injection drug use.
• MSM/IDU: Cases in males who report both injection drug use and sexual contact with other males.
• Heterosexual Sex: Cases in persons who report specific heterosexual sex with a person with, or at 
increased risk for, HIV infection (e.g. an injection drug user). The sub-categories for this mode of 
transmission are listed below.
- Heterosexual Sex w/ an Injection Drug User
- Heterosexual Sex w/ a person w/ HIV infection or AIDS
- Heterosexual Sex w/ Bisexual male
- Other Heterosexual Sex: Includes all other sub-categories of risk, such as heterosexual contact with a 
person infected through a blood transfusion.
• Presumed Heterosexual: Cases among females who report heterosexual sex but do not report any other 
personal risk or any knowledge of specific risk in their male sex partners. As of January 1, 2011, males 
that were previously grouped in this category are categorized as No Identified Risk. Presumed 
Heterosexual is an exposure mode category used by the Massachusetts HIV/AIDS Surveillance Program. 
The Centers for Disease Control and Prevention (CDC) categorizes these cases as No Identified Risk.
• Pediatric: Infection before the age of 13 years, including mother to child transmission through pregnancy, 
childbirth or breastfeeding and blood transfusions to children.
• NIR (No Identified Risk): Cases in persons with no reported history of exposure to HIV through any of 
the listed exposure categories. Follow-up is conducted to determine risk for those cases that are initially 
reported without a risk identified. Includes cases among males who were previously categorized as 
Presumed Heterosexual.
II. References to Newly Diagnosed HIV Infections
Due to reporting delays related to site-specific reporting issues, all HIV/AIDS data reflect HIV diagnosed
through 2013. Newly diagnosed HIV infections/cases include all persons diagnosed with HIV in 2013, 
including those who were concurrently or subsequently diagnosed with AIDS. 
III. Race/Ethnicity of STI and HIV/AIDS Cases
Race/ethnicity references to white residents and black residents represent persons who are white non-
Hispanic and black non-Hispanic, respectively. All references to Hispanic/Latino for race/ethnicity represent
persons of Hispanic/Latino heritage regardless of race. 
IV. STI Case Reports and Analyses
All information on STI cases reflect year of diagnosis and all incidence calculations represent crude rates. The
source of denominators for calculating rates was the Annual Estimates of the Resident Population for Selected Age
Groups by Sex for the United States, States, Counties, and Puerto Rico Commonwealth and Municipios: April 1,
2010 to July 1, 2014; Source: U.S. Census Bureau, Population Division; Release Date: June 2015 and Table 2.
Intercensal Estimates of the Resident Population by Sex and Age for Massachusetts: April 1, 2000 to July 1, 2010
(ST-EST00INT-02-25); Source: U.S. Census Bureau, Population Division; Release Date: October 2012. The 
distribution of STI cases with unknown race/ethnicity, gender and age has changed from the last issue of this 
report: cases with unknown values are now redistributed for incidence rate calculations instead of excluded. Due 
to this change, STI incidence rates by race/ethnicity are slightly higher for all years than previously reported. 
V. Cell Suppression Methodology 
Values less than five are suppressed for populations less than 50,000 or for unknown values. Additional 
values may be suppressed to prevent back calculation.
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Policy Development 
and Administration
Sylvie Ratelle STD/HIV 
Prevention Training 
Center
STD/HIV/AIDS 
Surveillance and 
Epidemiology
STD Clinical Services 
STD Disease Intervention Field
Services and STD 
Partner Notification
STD Health Education, 
Training, and Prevention
HIV/AIDS Resource, 
Allocation, Policy, 
and Programs
Population Health and 
Community Engagement, 
Consumer Office
Medical Case Management 
and Health Related Support 
Services, Prevention and 
Screening, Contracts 
Viral Hepatitis Programs
Viral Hepatitis Surveillance 
and Epidemiology
Kathleen Roosevelt (Director, STD
Prevention Division)
Katherine Hsu (Medical Director)
Janine Dyer (Deputy Director)
Betsey John (Director, HIV/AIDS 
and STD Surveillance)
Katherine Hsu (Medical Director)
Barbara Coughlin (Public Health Nurse)
David Goudreau
(Field Operations Manager)
Christopher Borger
(Field Operations Manager)
Brenda Hernandez 
(Special Projects Coordinator)
Dawn Fukuda (Director, Office of
HIV/AIDS)
Barry Callis 
(Director of Behavioral Health and
Infectious Disease Prevention)
Paul Goulet 
(Director of Consumer Office)
Linda Goldman
(Director of Health Program 
and Disease Prevention)
Daniel Church (Viral Hepatitis 
Prevention Coordinator, Division of
Epidemiology and Immunization)
Shauna Onofrey (Viral Hepatitis
Surveillance Coordinator)
Kathleen.roosevelt@state.ma.us
Katherine.Hsu@state.ma.us
Janine.Dyer@state.ma.us
Betsey.John@state.ma.us
Katherine.Hsu@state.ma.us
Barbara.Coughlin@state.ma.us
David.Goudreau@state.ma.us
Chris.Borger@state.ma.us
Brenda.Hernandez@state.ma.us
Dawn.Fukuda@state.ma.us
Barry.Callis@state.ma.us
Paul.B.Goulet@state.ma.us
Linda.Goldman@state.ma.us
Daniel.Church@state.ma.us
Shauna.Onofrey@state.ma.us
Topic Contact Email
Office of HIV/AIDS
Viral Hepatitis Program
617-983-6941
617-983-6948
617-983-6964
617-983-6570
617-983-6948
413-586-7525
617-983-6835
617-983-6930
617-983-6943
617-624-5303
617-624-5316
617-624-5389
617-624-5347
617-983-6830
617-983-6776
Phone
Division of STD Prevention & HIV/AIDS Surveillance, and Ratelle STD/HIV Prevention Training Center
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STD, HIV/AIDS AND VIRAL HEPATITIS RESOURCES
Type of Training
STD Education, STD Partner Notification, 
and STD Reporting 
HIV/AIDS Reporting and 
Surveillance Projects
HIV/AIDS Provider Trainings
Viral Hepatitis Education
STD Diagnosis, Treatment, 
and Management
Material and Clinical Toolkits
Type of Material
STD, HIV, Viral Hepatitis Fact Sheets
HIV/AIDS Reporting for Health Care 
Providers Brochure
STD and HIV Posters and Brochures
STD Diagnosis, Treatment, and 
Management Toolkits
MDPH and MDPH Funded Websites
Contact Information and Website
617-983-6940
www.mass.gov/dph/cdc/std
617-983-6560
www.mass.gov/dph/cdc/aids
617-624-5338
www.mass.gov/dph/aids
617-983-6800
http://www.mass.gov/eohhs/gov/departments/dph/pro-
grams/id/epidemiology/hepatitis/hepatitis-c/viral-hepatitis-
educational-materials.html  
617-983-6945
www.RatellePTC.org
Contact Information and Website
617-983-6940
http://www.mass.gov/eohhs/gov/departments/dph/
programs/id/epidemiology/factsheets.html#std 
617-983-6560
http://www.mass.gov/eohhs/gov/departments/dph/
programs/id/hiv-aids/reporting/ 
617-983-6800
https://massclearinghouse.ehs.state.ma.us/ 
617-983-9645
www.RatellePTC.org
Training
Professional training to community based organizations, local public health departments, and medical
providers can be requested and is free of charge. 
Division of STD Prevention www.mass.gov/dph/cdc/std
HIV/AIDS Bureau www.mass.gov/dph/aids
HIV/AIDS Surveillance www.mass.gov/dph/cdc/aids
Viral Hepatitis Program www.mass.gov/hepc
Sylvie Ratelle STD/HIV Prevention Training Center www.RatellePTC.org
National Websites 
Center for Disease Control and Prevention www.cdc.gov
Division of STD Prevention www.cdc.gov/std
Division of HIV/AIDS Prevention www.cdc.gov/hiv
Division of Viral Hepatitis www.cdc.gov/hepatitis
National Network of STD/HIV Prevention 
Training Centers www.nnptc.org
CDC funded viral hepatitis online training http://depts.washington.edu/hepstudy/ 
Health education materials and clinical toolkits can be requested free of charge.
